4.7 Letter

Is a Single BRAF Wild-Type Test Sufficient to Exclude Melanoma Patients from Vemurafenib Therapy?

Journal

JOURNAL OF INVESTIGATIVE DERMATOLOGY
Volume 134, Issue 5, Pages 1468-1470

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/jid.2013.378

Keywords

-

Categories

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available